In obesity and diabetes, the AMPK–YAP–c‐Jun N‐terminal kinase (JNK) axis upregulates YAP target genes and inflammatory markers in endothelial cells, contributing to vascular dysfunction [225] (Figure S3B). This evidence concerns the gene YAP1 and diabetes mellitus.